Explore

Yondr Pouches Gain Traction in U.S. Venues and Schools for Creating Phone-Free Environments

Yondr Pouches Gain Traction in U.S. Venues and Schools for Creating Phone-Free Environments

Yondr, a company founded in 2014, is experiencing significant growth in the U.S. by providing magnetic pouches that lock smartphones, creating phone-free spaces in various settings. Initially adopted by a biker bar in Oakland, California, to prevent filming of burlesque shows, Yondr pouches are now widely used in concerts, including those by artists like Jack White and Harry Styles, and have expanded to schools in all 50 states. The company's solution aims to combat digital distraction, allowing attendees and students to engage more fully with their immediate environment. While some studies on school phone bans have shown mixed results regarding academic improvement, the trend reflects a growing desire among artists, educators, and the public to reduce smartphone dependency and foster more present interactions.

AACR Conference Addresses Cancer Health Disparities with Focus on Actionable Solutions

AACR Conference Addresses Cancer Health Disparities with Focus on Actionable Solutions

The 19th AACR Conference on the Science of Cancer Health Disparities, held from October 18-21, focused on identifying and implementing actionable solutions to address persistent inequities in cancer care. Monica L. Baskin, PhD, Director and Jeanette and Eric Lipman Chair in Oncology of the VCU Massey Comprehensive Cancer Center, emphasized that while significant progress has been made in cancer screening, treatment, and prevention since the National Cancer Institute's establishment in 1937, these advancements have not benefited all populations equally. The conference highlighted strategies such as community health worker programs, which have proven cost-effective in increasing screening rates for breast, cervical, and colorectal cancers. Additionally, the importance of ensuring underrepresented populations participate in clinical trials was stressed, with Baskin noting their willingness to participate if asked. The discussion also touched upon the potential of artificial intelligence (AI) to identify regio...

Representative Jake Auchincloss Introduces 'Faster Clinical Trials Act' to Modernize Drug Development

Representative Jake Auchincloss Introduces 'Faster Clinical Trials Act' to Modernize Drug Development

U.S. Rep. Jake Auchincloss, D-Mass., has introduced H.R. 10857, known as the 'Faster Clinical Trials Act.' This comprehensive bill aims to accelerate medical research, enhance clinical trial efficiency, and strengthen oversight in drug development and labeling. Key provisions include establishing an FDA-led 'Cures in Care' program to facilitate routine clinical trials within standard healthcare settings, promoting decentralized methods, and prioritizing underserved populations. The bill also mandates more standardized data sharing for point-of-care trials, expands FDA and CMS guidance on trial funding, and updates oversight rules. Furthermore, it seeks to modernize the review of early-stage trials, align with international standards, and scrutinize foreign data used in FDA decisions. The legislation also proposes creating an FDA Rare Disease Innovation Hub to expedite rare disease trials and biomarker development. Additionally, it would establish an Oncology Center of Excellence and a new FDA process for r...

Oakland City Council Reaches Tentative Agreement to Retrain or Reassign Workers Displaced by AI

Oakland City Council Reaches Tentative Agreement to Retrain or Reassign Workers Displaced by AI

The city of Oakland has reached a tentative three-year labor agreement with the International Federation of Professional and Technical Engineers Local 21. This agreement includes a significant provision that mandates the city to retrain or reassign city workers whose jobs are displaced by Artificial Intelligence (AI), rather than resorting to layoffs. The provision focuses on ensuring continued employment for affected individuals through new training or placement in different roles. This development follows a 94.1% strike-authorization vote by Local 21 members on October 22, 2026, which put pressure on the city to address worker concerns regarding AI. Beyond job displacement, employees also expressed worries about increased surveillance and inaccurate performance assessments by AI systems. The tentative deal was announced on October 31, 2026, leading to the postponement of a planned November 5 strike.

Broad Genomic Testing Extends Lifespan for Advanced Lung Cancer Patients, Study Finds

Broad Genomic Testing Extends Lifespan for Advanced Lung Cancer Patients, Study Finds

Research published in JNCCN—Journal of the National Comprehensive Cancer Network indicates that comprehensive genomic sequencing of lung cancer tumors before initial treatment can prolong the lives of patients with advanced disease. The study, which analyzed electronic health record data from approximately 280 U.S. academic and community oncology clinics between 2016 and 2022, involved tens of thousands of patients. It found that broad genomic sequencing (BGS), which examines hundreds of genes, led to an average increase of two months in overall survival for patients with stage IIIB–IV non-small cell lung cancer (NSCLC) compared to more limited biomarker testing. Patients undergoing BGS lived a median of 16 months versus 14 months for those with focused testing. Additionally, BGS resulted in higher biomarker positivity (60% vs. 22%) and greater use of targeted therapies (19% vs. 16%). However, BGS did not show improved outcomes in the matched second-line cohort.

Stephen Curry and Kevin Durant meet again as Warriors head to Houston

Stephen Curry and Kevin Durant meet again as Warriors head to Houston

Steph and KD square off for the 41st time, with the Warriors chasing nine straight and Durant looking to make it 8–3.

Milken Institute Report Identifies Gaps in Women's Cancer Care, Proposes Solutions

Milken Institute Report Identifies Gaps in Women's Cancer Care, Proposes Solutions

A new report from the Milken Institute Women’s Health Network highlights significant gaps in cancer care systems for women across various life stages. The report, which draws on published research and insights from over 20 oncologists, clinicians, and patient advocates at the 2026 American Society of Clinical Oncology (ASCO) annual meeting, maps women's cancer experiences from childhood through survivorship. It identifies critical points where prevention, screening, treatment, and survivorship care often fail. Key areas for improvement include expanding prevention efforts, such as HPV vaccination through schools and community sites, and improving transitions between different stages of care, like pediatric to adult care or screening to follow-up. The report also emphasizes the need to integrate female-specific care, such as fertility counseling and menopause support, into routine oncology practice.

Massive Bio's AI Platform Accelerates Clinical Trial Matching for Cancer Patients

Massive Bio's AI Platform Accelerates Clinical Trial Matching for Cancer Patients

Massive Bio, co-founded by Dr. Arturo Loaiza-Bonilla, has developed an AI platform that significantly speeds up patient characterization and clinical trial matching, particularly in oncology. This platform can complete end-to-end patient matching in as little as 17 seconds by analyzing structured data from U.S. electronic medical records and cross-referencing it with a clinical trial database developed in collaboration with OpenAI. The technology has assisted over 200,000 patients across 17 countries and has been recognized with an NCI SBIR grant. Despite its efficiency in identifying potential matches, Dr. Loaiza-Bonilla notes that AI's ability to fully address inequities in clinical trial access remains uncertain, as challenges in patient engagement, education, and the 'last mile' of enrollment persist. He emphasizes that while AI can improve the matching process, human factors are still critical for successful enrollment.

On This Day in 1936, the Bay Bridge Opened to California Drivers

On This Day in 1936, the Bay Bridge Opened to California Drivers

The San Francisco–Oakland Bay Bridge, a landmark connecting two major California cities, has a rich history intertwined with ambitious construction...

Long Beach Implements Speed Camera Program to Combat Rising Fatal Crashes

Long Beach Implements Speed Camera Program to Combat Rising Fatal Crashes

Long Beach, California, has activated a speed camera program at 18 locations across the city, with two cameras in each City Council district. These cameras began issuing warnings on October 7 and will start issuing citations on December 7. The initiative aims to address a significant increase in fatal crashes, with 53 recorded last year—the highest in over a decade—and 41 so far this year, surpassing the number of homicides. Half of the camera locations are on streets with high rates of deadly or severe accidents, while the other half are situated in school zones or areas known for street racing. The cameras capture only the rear license plates of vehicles, and citations, ranging from $50 to $500 depending on the speed over the limit, are mailed to the registered owner. Long Beach officials estimate the program will generate approximately $5 million in revenue in its first year, with half covering administrative costs and the remainder funding traffic-calming measures in high-need neighborhoods. This progr...

Precision Medicine Advances with Focus on Individualized Treatments and Genetic Data

Precision Medicine Advances with Focus on Individualized Treatments and Genetic Data

Precision medicine is an evolving field that utilizes advanced tools and technologies to customize medical treatments for individual patients. This approach considers a patient's unique genetic, environmental, and lifestyle profiles. By analyzing genetic data, medical researchers are developing targeted treatments that aim to be more effective than conventional, generalized medicines. Researchers are actively exploring new avenues within precision medicine, including genetic testing and personal genomics. The field is also addressing the challenge of scaling highly personalized therapies beyond single patients, drawing parallels with existing precision medicine models in oncology. The Precision Medicine World Conference (PMWC) Pioneer Award highlights research contributing to new cancer treatment options, emphasizing a continuous cycle of measurement, learning, and refinement to enhance the safety, practicality, and patient burden of new treatments.

American Cancer Society calls for routine prostate cancer screening in guideline change

American Cancer Society calls for routine prostate cancer screening in guideline change

By Nancy Lapid Nov 12 (Reuters) - Routine prostate cancer screening is now advised for many men, the American Cancer Society announced on Thursday in a major guideline change, saying it believes the possible benefits now outweigh potential harms given medical advances and accumulating evidence.